Mainz Biomed (MYNZ) Stock Price, Quote, News & History

Comments

Mainz Biomed NV (MYNZ) Stock Price, Quote, News & History

MYNZNASDAQ

Trade with Public

$0.8101

-0.0199-2.40%

At close: Mar 9, 5:00 PM EST

$0.8300

0.01992.46%

After Hours: 7:29 PM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$0.83

Close

$0.81

Volume / Avg.

131.69K / 469.40K

Day Range

$0.79 - $0.87

52 Wk Range

0.55 - 5.62

Market Cap

$7.12M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

1.98%

Days to Cover

1

Recent Mainz Biomed NV News

Partner Content

Mainz Biomed Update: Early Detection Test For Pancreatic Cancer Demonstrates Never Before Seen Results, Company Ready To Launch ColoAlert In Switzerland

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Partner Content

Mainz Biomed Narrows Its Losses, Grows Revenue For Full Year 2024

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.46M

Investing Cash Flow (TTM)

-229.28K

Financing Cash Flow (TTM)

16.72M

Free Cash Flow (TTM)

-15.75M

Capital Expenditure (TTM)

-285.41K

Net Change in Cash (TTM)

1.03M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$11.57M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.84

PB Ratio (TTM)

4.12

Earnings Yield % (TTM)

-636.14%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.20

Company Debt

Total Debt

$1.62M

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$353.67K

Total Cash

$1.91M

Debt to Equity

1.23

Issuance of Debt (TTM)

-$353.67K

Repayment of Debt (TTM)

-$1.35M

Key Statistics

Open

$0.83

Close

$0.81

Volume / Avg.

131.69K / 469.40K

Day Range

$0.79 - $0.87

52 Wk Range

0.55 - 5.62

Market Cap

$7.12M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

1.98%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal ca...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Mainz Biomed (MYNZ) stock?

A

You can purchase shares of Mainz Biomed (NASDAQ:MYNZ) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Mainz Biomed (MYNZ) competitors?

A

Other companies in Mainz Biomed’s space includes: Ernexa Therapeutics Inc (NASDAQ:ERNA), Alzamend Neuro Inc (NASDAQ:ALZN), Immuron Ltd (NASDAQ:IMRN), Can Fite Biopharma Ltd (AMEX:CANF) and Lunai Bioworks Inc (NASDAQ:LNAI).

Q

What is the forecast, or price target, for Mainz Biomed (MYNZ) stock?

A

Mainz Biomed has a consensus price target of $14.00.

Q

What is the current price for Mainz Biomed (MYNZ)?

A

The stock price for Mainz Biomed (NASDAQ: MYNZ) is $0.83 last updated March 9, 2026 at 7:29 PM EDT.

Q

Does Mainz Biomed (MYNZ) pay a dividend?

A

There are no upcoming dividends for Mainz Biomed.

Q

When is Mainz Biomed (NASDAQ:MYNZ) reporting earnings?

A

Mainz Biomed does not have any upcoming earnings scheduled.

Q

Is Mainz Biomed (MYNZ) going to split?

A

There is no upcoming split for Mainz Biomed.

Q

What sector and industry does Mainz Biomed (MYNZ) operate in?

A

Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Ernexa Therapeutics Inc

Can Fite Biopharma Ltd

Bolt Biotherapeutics Inc

NASDAQ:BOLT

$4.11

-0.19%

AlphaTON Capital Corp

NASDAQ:ATON

$0.40

1.68%

AIxCrypto Holdings Inc

NASDAQ:AIXC

$1.18

-2.39%

Key Statistics

Open

$0.83

Close

$0.81

Volume / Avg.

131.69K / 469.40K

Day Range

$0.79 - $0.87

52 Wk Range

0.55 - 5.62

Market Cap

$7.12M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

1.98%

Days to Cover

1

Recent Mainz Biomed NV News

Partner Content

Mainz Biomed Update: Early Detection Test For Pancreatic Cancer Demonstrates Never Before Seen Results, Company Ready To Launch ColoAlert In Switzerland

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Partner Content

Mainz Biomed Narrows Its Losses, Grows Revenue For Full Year 2024

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.46M

Investing Cash Flow (TTM)

-229.28K

Financing Cash Flow (TTM)

16.72M

Free Cash Flow (TTM)

-15.75M

Capital Expenditure (TTM)

-285.41K

Net Change in Cash (TTM)

1.03M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$11.57M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.84

PB Ratio (TTM)

4.12

Earnings Yield % (TTM)

-636.14%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.20

Company Debt

Total Debt

$1.62M

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$353.67K

Total Cash

$1.91M

Debt to Equity

1.23

Issuance of Debt (TTM)

-$353.67K

Repayment of Debt (TTM)

-$1.35M

Key Statistics

Open

$0.83

Close

$0.81

Volume / Avg.

131.69K / 469.40K

Day Range

$0.79 - $0.87

52 Wk Range

0.55 - 5.62

Market Cap

$7.12M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

1.98%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal ca...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry